Patented Therapeutic Plasma Exchange Protocols Including Mold Detox Comes to Boulder/Denver and Nationwide
DENVER — MDLifespan, a physician-led medical technology company specializing in Advanced Serial Therapeutic Plasma Exchange, has announced a major expansion through a new partnership with Dr. Jill Carnahan and her clinic, Flatiron Functional Medicine, in the Boulder, Colorado area.
The collaboration brings MDLifespan’s suite of Advanced Therapeutic Plasma Exchange protocols to Colorado patients for the first time, including MDL Brain, MDL Heart, MDL Toxin, MDL Immunity, MDL Longevity, and MDL Anti-Cancer.
In addition, MDLifespan’s MDL Mold Protocol is now offered at Flatiron Functional Medicine and was scheduled to begin rolling out to MDLifespan locations nationwide in August.
Advanced Therapeutic Plasma Exchange Comes to Boulder
The partnership expands access to physician-led Advanced Therapeutic Plasma Exchange in Boulder through Flatiron Functional Medicine, the Colorado clinic founded by Dr. Jill Carnahan.
Dr. Carnahan collaborated with MDLifespan to develop the MDL Mold Protocol, combining her clinical experience in mold-related health concerns with MDLifespan’s plasma exchange protocols.
“Mycotoxins and mold-related biotoxins can persist in the body and drive ongoing inflammation, neurotoxicity, and immune dysregulation even after environmental remediation,” said Dr. Jill Carnahan, MD, founder of Flatiron Functional Medicine. “By collaborating with MDLifespan, we are offering patients an evidence-based, personalized approach to detoxification that addresses these circulating toxicants at a fundamental level.”
A Partnership Focused on Environmental Exposure and Health
The collaboration brings together Flatiron Functional Medicine’s clinical experience with MDLifespan’s physician-led Advanced TPE protocols.
“Flatiron Functional Medicine and MDLifespan share a mission: to get to the root of illness and help patients heal at a cellular level,” said Dr. Paul Savage, founder of MDLifespan. “Dr. Jill and her team are known nationally for their commitment to excellence, and we’re proud to bring our science-backed PlasmaXchange protocols to their clinic.”
“This partnership allows us to offer our patients cutting-edge therapies that address the toxic burden many of them face,” added Dr. Jill.
MDL Mold Protocol Expands Nationwide
Mold-related environmental exposure can be difficult to evaluate, particularly when individuals continue to experience symptoms after addressing the source of exposure.
The MDL Mold Protocol was developed specifically around mold-related toxin burden and incorporates Advanced Therapeutic Plasma Exchange within a broader physician-led protocol.
The original release reported clinical results showing reductions in measured mold toxins following the protocol. The specific quantitative claims regarding toxin removal should be interpreted in the context of MDLifespan’s underlying clinical data and verified supporting evidence.
The protocol also includes MDL Clean, a daily nutritional supplement developed with Dr. Jill Carnahan for individuals participating in the mold-focused protocol.
“Plasmapheresis has been shown in peer-reviewed studies to reduce levels of autoantibodies, proinflammatory cytokines (such as IL-6, TNF-α), complement components (e.g., C3a, C4a), and lipid-bound toxins,” adds Dr. Jill. “Emerging clinical observations suggest that it may also aid in the removal of lipophilic mycotoxins bound to albumin and other plasma proteins, potentially alleviating symptoms such as cognitive dysfunction, fatigue, and systemic inflammation in susceptible individuals.”
“This isn’t just better—it’s transformative,” said Savage. “Mold toxicity patients are some of the sickest we see, and with MDL Mold, we’re finally giving them a real solution.”
Advanced TPE Protocols Available in Colorado
The partnership gives patients in the Boulder area access to a broader suite of MDLifespan protocols, including:
- MDL Brain
- MDL Heart
- MDL Toxin
- MDL Immunity
- MDL Longevity
- MDL Anti-Cancer
- MDL Mold
Each protocol is structured around physician oversight, diagnostic evaluation, and individualized care planning.
MDLifespan’s Advanced Serial Therapeutic Plasma Exchange protocols are designed to incorporate plasma exchange with relevant laboratory testing, biomarker assessment, and other protocol components based on the individual’s clinical plan.
Expanding Advanced TPE Nationwide
The Boulder-area partnership represents part of MDLifespan’s broader effort to expand access to Advanced Therapeutic Plasma Exchange through physician-led clinical partnerships across the United States.
The MDL Mold Protocol was also scheduled to roll out to additional MDLifespan locations nationwide, expanding access for patients seeking physician-led evaluation of mold-related environmental exposure and toxin burden.
Originally published via our press platform and republished in our official newsroom.
Jessica Rafaeil is a journalist and wellness writer specializing in therapeutic plasma exchange, sleep, nutrition, and alternative medicine. With over eight years of experience covering health trends, she has contributed to publications such as US Black Engineer and IT, Women of Color, Hispanic Engineer, Digital Journal, and Sway’s Universe. Jessica combines journalism with branding expertise to elevate the voices of health-focused brands while advocating for diversity and inclusion in media.